Object Details
- Schering Corporation
- Description (Brief)
- Intron A is an injectible recombinant pharmaceutical used to treat hairy cell leukemia.
- Recombinant pharmaceuticals are created by inserting genes from one species into a host species, often yeast or bacteria, where they do not naturally occur. The genes code for a desired product, and therefore the genetically modified host organisms can be grown and used as a kind of living factory to produce the product. In this case, genes coding for human white blood cell interferons are inserted into bacteria. Interferon is a substance that is naturally made by the body to fight infections and tumors. Bacteria produce the interferons, which are harvested and used as the active ingredient in Intron A.
- Object consists of a cardboard box containing a second box, two glass bottles (one of the active pharmaceutical and one of the dilutent), and two product inserts.
- Location
- Currently not on view
- Credit Line
- Gift of Schering Corporation, through Steven Schneider, Vice-President
- 1988
- product expiration date
- 1988-03
- ID Number
- 1987.0781.03
- accession number
- 1987.0781
- catalog number
- 1987.0781.03
- Object Name
- biological
- pharmaceutical
- Physical Description
- Interferon alfa-2b recombinant, 10 million IU per vial (overall active ingredients)
- Dilutent for Intron A, Bacteriostatic water for injection, 2 mL (overall ingredients)
- Measurements
- overall: 8.8 cm x 6.2 cm x 3.5 cm; 3 7/16 in x 2 7/16 in x 1 3/8 in
- overall: 3 3/8 in x 2 3/8 in x 1 1/2 in; 8.5725 cm x 6.0325 cm x 3.81 cm
- place made
- United States: New Jersey, Kenilworth
- See more items in
- Medicine and Science: Medicine
- Health & Medicine
- The Antibody Initiative
- Biotechnology and Genetics
- Recombinant Pharmaceuticals
- Science & Mathematics
- Antibody Initiative: Monoclonal Antibodies
- National Museum of American History
- Record ID
- nmah_1000951
- GUID (Link to Original Record)
- https://n2t.net/ark:/65665/ng49ca746a8-5e25-704b-e053-15f76fa0b4fa
.jpg)
